The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Intratympanic Steroid Treatment in Idiopathic Sudden Sensorineural Hearing Loss: A Control Study
Abstract
BACKGROUND AND OBJECTIVE: Although systemic steroids in sudden sensorineural hearing loss (SSHL) appears to be the most effective and the most widely accepted treatment today, a significant number of patients do not respond to steroid treatment or they cannot receive steroids for medical reasons. Intratympanic (IT) administration of steroids appears to be an alternative or additional method of management without the side effects of intravenous steroids. The aim of this study is to investigate the effectiveness and safeness of IT administration of steroids in patients who had not responded to IV treatment and to compare treatment efficacy with controls. STUDY DESIGN AND SETTING: Our study consisted of 37 patients with SSHL who, at the end of 10 days of therapy with intravenous steroids as a 1st line treatment, had pure‐tone 4‐frequency (0.5, 1, 2, and 4 kHz) average (PTA) of worse than 30 dB or worse than 10 dB from the contralateral ear (defined as failed intravenous treatment). They were randomized into 2 groups, treatment and control. The 19 patients of the treatment group received approximately 0.5 mL sterile aqueous suspension of methylprednisolone acetate in a concentration of 80 mg/2 mL by direct injection. The procedure was carried out 4 times within a 15‐day period. An audiogram was performed before each injection and approximately 1.5 months after the last session. RESULTS: All patients tolerated the procedure well. No perforation or infection was noticed in any of the patients at their last visit. With regard to the 19 patients who received intratympanic treatment, in 9 patients, the PTA threshold improved more than 10 db, in 10 patients there was no change greater than 10 db, and no patients deteriorated more than 10 db. In the control group, none of the patients showed any change greater than 10 db. The difference was statistically significant (P = 0.002). The treatment group showed an improvement in mean PTA of 14.9 dB, whereas the control group showed a deterioration of 0.8 dB, and this difference also was statistically significant (P = 0.0005). IT treatment (P = 0.0001), better post‐IV PTA (P = 0.0008), and absence of vertigo (P = 0.02) were good predictors of the outcome. In contrast, sex, age, affected ear, days to admission, and pattern of the initial audiogram showed no significant influence on the outcome. CONCLUSION AND SIGNIFICANCE: IT steroid administration after failed intravenous steroids is a safe and effective treatment in sudden sensorineural hearing loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sudden hearing loss: eight years’ experience and suggested prognostic table
Byl, F. M. (1984) · The Laryngoscope · doi:10.1288/00005537-198405000-00014 · Cited by 886
Parnes, L. S., Sun, A., & Freeman, D. J. (1999) · The Laryngoscope · doi:10.1097/00005537-199907001-00001 · Cited by 634
The treatment of idiopathic sudden sensorineural hearing loss
Siegel, L. G. (1975) · Otolaryngologic Clinics of North America · doi:10.1016/s0030-6665(20)32783-3 · Cited by 418
Sudden sensorineural hearing loss
Hughes, G. B., Freedman, M. A., Haberkamp, T. J., & Guay, M. E. (1996) · Otolaryngologic Clinics of North America · doi:10.1016/s0030-6665(20)30362-5 · Cited by 323
Cited by
Clinical Practice Guideline: Sudden Hearing Loss
Stachler, R. J., Chandrasekhar, S. S., Archer, S. M., Rosenfeld, R. M., Schwartz, S. R., Barrs, D. M., Brown, S. R., Fife, T. D., Ford, P., Ganiats, T. G., et al. (2012) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599812436449 · Cited by 971
Sajjadi, H., & Paparella, M. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61161-7 · Cited by 583
Steroids for idiopathic sudden sensorineural hearing loss
Wei, B. P., Stathopoulos, D., & O'Leary, S. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003998.pub3 · Cited by 354
Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy
Haynes, D. S., O'Malley, M., Cohen, S., Watford, K., & Labadie, R. F. (2007) · The Laryngoscope · doi:10.1097/01.mlg.0000245058.11866.15 · Cited by 289
International consensus (ICON) on treatment of sudden sensorineural hearing loss
Marx, M., Younes, E., Chandrasekhar, S. S., Ito, J., Plontke, S., O’Leary, S., & Sterkers, O. (2018) · European Annals of Otorhinolaryngology, Head and Neck Diseases · doi:10.1016/j.anorl.2017.12.011 · Cited by 152
Metadata
- Authors
- Xenellis, J., Papadimitriou, N., Nikolopoulos, T., Maragoudakis, P., Segas, J., Tzagaroulakis, A., & Ferekidis, E.
- Venue
- Otolaryngology–Head and Neck Surgery
- Publisher
- Wiley
- Published
- 2006-06
- Volume
- 134
- Issue
- 6
- Pages
- 940-945
- ISSN
- 0161-6439 (ISSN-L)
- 0194-5998
- 1097-6817
- OpenAlex
- W2051128881
- Cited by
- 166
- References
- 4
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intratympanic Steroid Treatment in Idiopathic Sudden Sensorineural Hearing Loss: A Control Study. https://app.cochat.ai/papers/10.1016/j.otohns.2005.03.081
- The paper
- Xenellis, J., Papadimitriou, N., Nikolopoulos, T., Maragoudakis, P., Segas, J., Tzagaroulakis, A., & Ferekidis, E. (2006). Intratympanic Steroid Treatment in Idiopathic Sudden Sensorineural Hearing Loss: A Control Study. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1016/j.otohns.2005.03.081
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.